Dr. Harold M. Szerlip, MD

Dr. Szerlip practices at MUSC University Hospital in Charleston, South Carolina.

Dr. Szerlip's NPI, 1942394432, was assigned on October 2, 2006. Dr. Szerlip holds South Carolina license 23094.

Dr. Szerlip's primary practice is MUSC University Hospital, at 171 Ashley Ave, Charleston, SC 29425 in Charleston County. The practice phone is (843) 792-1414.

Dr. Szerlip's primary practice is MUSC University Hospital in Charleston, South Carolina. Dr. Szerlip is also affiliated with MUSC Health University Medical Center. The medical group on file is MUSC Health. Dmand AI also links Dr. Szerlip to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Szerlip practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Szerlip's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Szerlip's licenses on file in 3 states: South Carolina, Georgia and Texas.

CMS data shows 559 Medicare services from Dr. Szerlip across 6 procedure codes in 2024, for 197 Medicare patients. Medicare paid $38,509 for them.

CMS counts 197 Medicare patients who saw Dr. Szerlip in 2024. The largest group is 65 to 74, with 83 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 17% are also on Medicaid. Their average risk score is 3.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Szerlip's median patient age at 66, with 50% women.

In 2024, Dr. Szerlip wrote 532 Medicare Part D claims for 79 patients. 67% of them were for generic drugs. CMS names the drug for 422 of them, across 16 drugs with 11 or more claims each, at $97,163 in total drug cost. In 2023, CMS named 283 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Szerlip for performance year 2024, reported as part of a group. Dr. Szerlip accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Szerlip as offering telehealth.

CMS Open Payments shows 585 general payments to Dr. Szerlip from 33 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 52% of the total. AstraZeneca Pharmaceuticals LP paid the most, $150,711. It also lists 14 research payments totaling $1,608 from 2017 to 2018.